Literature DB >> 2991115

Linkage studies of X-linked mental retardation: high frequency of recombination in the telomeric region of the human X chromosome (fragile site/linkage/recombination/X chromosome).

K E Davies, M G Mattei, J F Mattei, H Veenema, S McGlade, K Harper, N Tommerup, K B Nielsen, M Mikkelsen, P Beighton.   

Abstract

One of the commonest forms of X-linked mental retardation is associated with a fragile site at Xq27 on the human X chromosome which can be visualised structurally after culturing cells in folate-deficient media. Unusually, the mutation can be transmitted through a phenotypically normal male. There is already some evidence that the gene loci for G6PD and factor IX are linked to this mental retardation locus. We have followed the inheritance of a DNA sequence 52A, in fragile site families that are also informative for factor IX. We demonstrate that these probes are localised at Xq27/Xq28-Xqter, close physically to the fragile site. We did not find close linkage between 52A, factor IX, and the fragile site in the families studied despite 52A and factor IX showing linkage in normal families. We discuss the importance of these data for the genetic mapping of this region of the human X chromosome and the implication for the use of these DNA probes for clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991115     DOI: 10.1007/bf00273451

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  43 in total

1.  Linkage relationships of X-linked enzymes glucose-6-phosphate dehydrogenase and hypoxanthine guanine phosphoribosyltransferase: recombination in female offspring of compound heterozygotes.

Authors:  U Francke; B Bakay; J D Connor; J G Coldwell; W L Nyhan
Journal:  Am J Hum Genet       Date:  1974-07       Impact factor: 11.025

2.  X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28.

Authors:  G R Sutherland; P L Ashforth
Journal:  Hum Genet       Date:  1979-04-17       Impact factor: 4.132

3.  Genetic mapping of the human X chromosome by using restriction fragment length polymorphisms.

Authors:  D Drayna; K Davies; D Hartley; J L Mandel; G Camerino; R Williamson; R White
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

4.  X-linked mental retardation with fragile X. A pedigree showing transmission by apparently unaffected males and partial expression in female carriers.

Authors:  K B Nielsen; N Tommerup; H Poulsen; M Mikkelsen
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

5.  5-Fluoro-2'-deoxyuridine induction of the fragile site on Xq28 associated with X linked mental retardation.

Authors:  N Tommerup; H Poulsen; K Brøndum-Nielsen
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

6.  A clinically useful DNA probe closely linked to haemophilia A.

Authors:  K Harper; R M Winter; M E Pembrey; D Hartley; K E Davies; E G Tuddenham
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

7.  Molecular cloning of the gene for human anti-haemophilic factor IX.

Authors:  K H Choo; K G Gould; D J Rees; G G Brownlee
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

Review 8.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

9.  Assignment of the haemophilia B (factor IX) locus to the q26-qter region of the X chromosome.

Authors:  Y Boyd; V J Buckle; E A Munro; K H Choo; B R Migeon; I W Craig
Journal:  Ann Hum Genet       Date:  1984-05       Impact factor: 1.670

10.  FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.

Authors:  T W Glover
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

View more
  29 in total

1.  Estimating the stability of the proposed imprinted state of the fragile-X mutation when transmitted by females.

Authors:  P J Follette; C D Laird
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

Review 2.  Twinning and mitotic crossing-over: some possibilities and their implications.

Authors:  G B Côté; J Gyftodimou
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

Review 3.  Medical genetics.

Authors:  M Super
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

4.  Genetic mapping of two new DNA markers in Xq26-q28 relative to the fragile-X syndrome locus.

Authors:  R Sood; L M Mulligan; R Poon; B N White; J J Holden
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

5.  Hot spot of recombination within DXS164 in the Duchenne muscular dystrophy gene.

Authors:  T Grimm; B Müller; M Dreier; E Kind; T Bettecken; G Meng; C R Müller
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

6.  Mental retardation in heterozygotes for the fragile-X mutation: evidence in favor of an X inactivation-dependent effect.

Authors:  M Rocchi; N Archidiacono; A Rinaldi; G Filippi; G Bartolucci; G S Fancello; M Siniscalco
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

7.  The role of recombination in the evolvement of the fragile X mutation.

Authors:  T Schaap
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

8.  Multilocus analysis of the fragile X syndrome.

Authors:  W T Brown; A Gross; C Chan; E C Jenkins; J L Mandel; I Oberlé; B Arveiler; G Novelli; S Thibodeau; R Hagerman
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

9.  Interpretation of the heterogeneity in the linkage relationships of DNA markers around the fragile X locus.

Authors:  R Winter; M Pembrey
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

10.  Hypothesis regarding the nature of the fragile X mutation. A reply to Winter and Pembrey.

Authors:  W T Brown; S L Sherman; C S Dobkin
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.